Nuzenio

Stock Titan Silence

Stock Titan Silence news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 11:33:40 GMTSilence Therapeutics trial cuts phlebotomies to 0.2 per patient - Stock Titan
Mon, 10 Aug 2026 11:26:59 GMTSilence Therapeutics (SLN) halves losses and funds operations into 2028 in Q2 update - Stock Titan
Mon, 10 Aug 2026 11:20:49 GMTSilence Therapeutics (SLN) halves net loss and boosts cash in Q2 2026 - Stock Titan
Mon, 10 Aug 2026 11:15:00 GMTSilence Therapeutics Finishes Dosing 48 Patients in Blood Disorder Trial - Stock Titan
Sun, 09 Aug 2026 21:00:00 GMTSilence Therapeutics to Discuss Divesiran Trial Results Aug. 10 - Stock Titan
Fri, 07 Aug 2026 22:52:53 GMTSilexion Therapeutics (NASDAQ: SLXN) files S-1 for best-efforts unit sale - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Silence.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.